Delivery Order SPE2DR25D2014-SPE2DR26FZ81C
Award Date 11/25/25
Potential Completion Date 11/26/25
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.56 to AmerisourceBergen Drug Corp for LIALDA DR 1.2 GM tablets (120-count supply) on December 17, 2025, with completion scheduled for December 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). The contract will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on July 24, 2025, for LIALDA DR 1.2 GM Tablet 120s, a pharmaceutical product used in the treatment of inflammatory bowel disease. This competitively awarded, firm fixed-price contract carries a ceiling value of $8,154.24 and is scheduled for completion by July 25, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- This is a $1,471.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LIALDA DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract has a completion date of July 10, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a $2,537.85 delivery order to AmerisourceBergen Drug Corp for 120 tablets of LIALDA DR 1.2 GM on September 16, 2025, with completion expected by September 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. LIALDA is a pharmaceutical treatment for inflammatory bowel disease, reflecting the agency's ongoing procurement of...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply LIALDA DR 1.2 GM tablets. The order, valued at $2,444.37, requires delivery of 120 tablets to a facility located in Conshohocken, Pennsylvania by November 21, 2023. No set aside designation was applied to this award made against an indefinite delivery contract held by Amerisourcebergen Drug Corp to provide pharmaceuticals and medical supplies to various...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,566,150 units of the prescription drug Lialda (mesalamine) in 120-count tablet bottles. The $2,807.73 firm fixed-price contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle...
- This federal contract award is for the delivery of Lialda DR 1.2 GM Tablet (120s) to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $2,613.18 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 8, 2021, with a completion date of September 9, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen Drug Corp holds with the DLA Troop...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,049.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of 120 tablets of the prescription medication LIALDA DR 1.2 GM with a completion date of February 2, 2024. This delivery order is part of Amerisourcebergen Drug Corp's larger $999,999,999.00 indefinite delivery contract with...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the pharmaceutical product Lialda DR 1.2 GM Tablet 120S, with a ceiling value of $3,410.52 and a period of performance through April 12, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp is the prime contractor and serves as a supplier of pharmaceuticals, medical supplies, and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566760943 - LIALDA DR 1.2 GM TABLET 120S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,922.17 and a completion date of December 19, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a...